Because accumulated evidence indicates that the targeting of NF-κB and MAPK signaling molecules ameliorates allergic asthma in experimental animals [51,52], the inhibition of JNK and IKK phosphorylation by AsE probably contributes to attenuating airway inflammation. Here, NFKB1 is linked to allergic asthma.